Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Short term Debt (2016 - 2024)

Historic Short term Debt for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q4 2024 value amounting to $773000.0.

  • Lifecore Biomedical, Inc. \De\'s Short term Debt changed 0.0% to $773000.0 in Q4 2024 from the same period last year, while for Nov 2024 it was $773000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $773000.0 for FY2024, which is 3327.59% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Short term Debt stood at $773000.0 for Q4 2024, which was down 0.0% from $773000.0 recorded in Q3 2024.
  • In the past 5 years, Lifecore Biomedical, Inc. \De\'s Short term Debt ranged from a high of $99.0 million in Q4 2022 and a low of $580000.0 during Q2 2023
  • Moreover, its 5-year median value for Short term Debt was $39.9 million (2022), whereas its average is $40.4 million.
  • Per our database at Business Quant, Lifecore Biomedical, Inc. \De\'s Short term Debt surged by 23854.48% in 2022 and then plummeted by 9940.92% in 2023.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Short term Debt stood at $77.0 million in 2020, then plummeted by 45.45% to $42.0 million in 2021, then surged by 135.6% to $99.0 million in 2022, then crashed by 99.22% to $773000.0 in 2023, then changed by 0.0% to $773000.0 in 2024.
  • Its last three reported values are $773000.0 in Q4 2024, $773000.0 for Q3 2024, and $773000.0 during Q2 2024.